ALK Positive

10/20/2026

Honoring an extraordinary physician, researcher, and friend to the ALK-positive community.

ALK Positive is proud to announce a $50,000 gift to the Ross Camidge, MD, PhD, Thoracic Oncology Endowed Program Support Fund at the University of Colorado Anschutz Medical Campus.

Dr. Ross Camidge has dedicated decades to advancing lung cancer research, improving treatment options, and caring for patients around the world. His innovative thinking, compassion, and commitment to pushing the boundaries of cancer care have made a lasting impact on our community.

This gift is more than a tribute. It's an investment in the future of thoracic oncology, supporting continued research, patient care, education, and the next generation of physicians and researchers.

We are deeply grateful for all Dr. Camidge has done and proud to help ensure the work he has inspired continues for years to come.

🔗 Read the full announcement: https://alkpositive.org/blog/alk-positive-donates-50000-to-honor-dr-ross-camidge-and-support-the-future-of-thoracic-oncology/

10/19/2026

🌍 ALK Positive is headed to ESMO Congress 2026!

Dr. Ken Culver and Yvonne Diaz will be in attendance October 20–27, connecting with leading physicians, researchers, and global partners to advance ALK-positive cancer research and amplify the voices of patients worldwide.

💚 Every connection is an opportunity to strengthen collaboration, accelerate research, and help bring more treatment options to people living with ALK-positive cancer.

👋 Attending ESMO? Be sure to say hello to Ken and Yvonne! We'd love to connect.

10/18/2026

10/17/2026

🧬 Could CAR T-cell therapy offer a new way to treat lung cancer?

It’s already transforming treatment for some blood cancers. Now researchers are exploring whether CAR T-cell therapy could help tackle lung cancer, including cancers that develop resistance to targeted therapies.

Join ALK Positive and EGFR Resisters tomorrow (Sunday, Oct 18th) for a special joint ALKtALK with Dr Kyle Concannon, thoracic oncologist and physician-scientist at the University of Colorado Anschutz Medical Campus.

Dr Concannon and team are developing ACES CAR T cells, an experimental approach with potential applications across ALK, EGFR, HER2 and other oncogene-driven lung cancers.

💙 What makes this research particularly exciting? It explores whether specially engineered immune cells could offer an entirely different way to target cancer cells.

We’ll discuss how the science works, where the research stands today and what needs to happen before the first clinical trial.

🎤 Plus, a live Q&A with Dr Concannon! Bring your questions and hear directly from the scientist developing this approach.

📅 Sunday, October 18
⏰ 7 p.m. ET
🔗 Register through the link in our bio!

Many patient communities. One shared goal: more treatment options for everyone. 💙

10/13/2026

🎥 The ALKtALK Replay is Now Available!

What’s new in ALK-positive cancer research, and what could it mean for you?

In our latest ALKtALK, Dr. Ken Culver, Executive Director and Medical Director of ALK Positive, shares updates on new clinical trials, emerging research, and projects supported by or connected to the ALK-positive community.

🔬 From new treatment approaches to ongoing research efforts, learn what’s happening in ALK-positive cancer research and how this work could help create more options for patients.

💚 Plus, get a special preview of More Research = More Dreams, our upcoming Lung Cancer Awareness Month campaign, and discover how you can get involved this November!

▶️ Watch the full ALKtALK replay now on our YouTube channel: https://www.youtube.com/watch?v=r3ocrSEb-jc

10/12/2026

What does survivorship mean when you're living with ALK-positive cancer?

Survivorship is about more than a diagnosis or treatment. It's about living, adapting, and finding ways to maintain quality of life along the way.

In this clip from our Season 7 premiere of ALKtALK, Dr. Eric Singhi, thoracic medical oncologist at MD Anderson Cancer Center, shares his perspective on what cancer survivorship means for the ALK-positive community.

In the full conversation, Dr. Singhi also discusses building a multidisciplinary care team, advances in lung cancer research, and practical questions about TKIs, cancer progression, vaccines, and more.

Whether you're newly diagnosed or have been living with ALK-positive cancer for years, this conversation offers valuable information and perspective on navigating life after diagnosis.

🎥 Watch the full ALKtALK replay: https://youtu.be/aIVlb1OiWxU

10/09/2026

How could we find new cancer treatments faster?

ALK Positive is helping fund researchers at Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute who are tackling that question—with an approach they’re now applying to lung cancer.

The team developed a faster way to identify and test treatments that help immune cells recognise and destroy cancer cells. Their first results are in lymphoma, where an experimental treatment both flags cancer cells for attack and blocks a signal that protects them.

Why does this matter to our ALK community? We need more treatment options, and developing them starts with finding new ways to target cancer.

This is early laboratory and animal research, not yet a treatment for ALK-positive cancer. But it shows how research supported by our community can help explore possibilities across cancer types.

Read more: https://bidmc.org/news-stories/all-news-stories/news/2026/09/researchers-pioneer-faster-cancer-treatment-development

10/01/2026

🔬 What’s next in ALK-positive cancer research?

Join us Sunday, Oct. 4 at 7 PM ET for a special ALKtALK with Dr. Ken Culver exploring the research, clinical trials, and collaborations helping shape what comes next for people living with ALK-positive cancer.

Dr. Culver will share updates on:
• New and emerging ALK research
• Clinical trials and expanding trial opportunities
• A new study exploring Zepbound for lorlatinib-associated weight gain
• The Global ALK Alliance and growing research collaborations

We’ll also share an early preview of Lung Cancer Awareness Month and how our community can get involved this November. 💜

Whether you’re newly diagnosed, exploring future treatment options, or simply want to stay informed, bring your questions and join us live.

📅 Sunday, Oct. 4
⏰ 7 PM ET
🔗 https://alkpositive.org/event/alktalk-oct4/

Can’t join live? The recording will be available afterward on our YouTube channel.

09/29/2026

09/27/2026

A white ribbon can open a conversation that someone might otherwise never have. It can challenge assumptions about lung cancer, make someone feel seen and invite others to stand alongside them. 🤍

For six years, Heidi and Pierre have helped people around the world have those conversations through The White Ribbon Project. Congratulations on the anniversary, and thank you for the care you bring to this community.

We’re thrilled to see Dr Sydney Barned and Jaymie Knox join the leadership team. Their voices and lived experience will help carry this work forward.

With love from the ALK Positive community. 💜